Drug Profile
Anticancer antibody-drug conjugate - Vaccinex/Catalent Pharma Solutions
Alternative Names: Anticancer ADC - Vaccinex/Catalent Pharma SolutionsLatest Information Update: 28 Dec 2021
Price :
$50
*
At a glance
- Originator Catalent Pharma Solutions; Vaccinex
- Class Antineoplastics; Drug conjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer